Valeant Pharmaceuticals Recent News
Valeant Spikes 6%, WSJ Says Company Close To Hiring Perrigo's Chief As New CEO
Report: Valeant More Likely To Sell Drugs Than Business Units
Valeant Shares Squeezed Higher As Ad Hoc Committee Closes Review, Finds No Added Issues
Valeant In Breach Of Canadian Regulations
Barron's Picks And Pans: FedEx, Ilumina And More
Canadian Authorities Could Be Looking Into Valeant
Hillary Clinton: 'I'm Going After' Valeant
UPDATE: Valeant Plunges 7% After Bearish Wells Fargo Report
Why Shares Of Valeant Pharmaceuticals Spiked
Investment Firm That Held Stake In Valeant Sued By Investors
Valeant Names Howard Schiller As Interim CEO As Mike Pearson Remains In The Hospital
Valeant Confirms CEO Will Be On Medical Leave Of Absence
Valeant's Stock Drops, Then Recovers, Following False Report Of FBI Raid
Barron's Recap: How To Live Well
Barron's Recap: Barnes & Noble, DSW Could Skyrocket
General Motors, Annaly Capital And Others Insiders Have Been Buying
Barron's Recap: Why Honeywell Is Better Than GE
Markets End Week On Positive Note As Investors Are Encouraged By Central Bank Developments In Europe, China
#PreMarket Primer: Friday, November 21: Immigration Reform Could Have Lasting Impact In More Ways Than One
Markets Mostly Lower As Americans Head To Vote, Oil Continues To Tumble
Markets Virtually Flat, Oil Continues To Decline Following Bearish Outlook
Cramer's Watchlist: Target And Lowe's Rebound As Hertz Remains In The Red
Dow Flirts With 19,000, S&P 500 Approaches 2,000 & NASDAQ Trading At 14-Year Highs